To explore the role of Langerhans cells in GVHD, the principal dendritic cells of the skin, we studied the fate of these cells in mice transplanted with allogeneic bone marrow. In contrast to ...

3 Chronic GvHD also tends to start with a burning rash on the same parts of the body, although it can be more severe and ...

Grafts in untreated diabetic mice are rejected ... in the absence of GVHD. Fourth, we can generate central transplantation tolerance that supports allogeneic skin transplantation and will surely ...

Healthcare professionals determine how to administer steroid therapy based on the severity of GVHD. If symptoms are localized and mild, such as a rash on the skin, topical products might be the ...

The team explored the potential of regenerative mesenchymal stem cells in reducing ocular inflammation in GVHD-infected mice. Their study, published in The Ocular Surface, explores the potential ...

Uday R. Popat, MD, discusses the rationale behind evaluating itacitinib over other JAK inhibitors for graft-vs-host disease ...

Theriva Biologics is putting more of its eggs in the VCN-01 basket as it unveils a change-up in its R&D focus. | Theriva ...

Or you may prefer to talk to friends and family, or other people who have similar problems. Chronic skin GvHD, steroid treatment, eye problems and weight loss can all affect how you look. This might ...

Gastrointestinal (GI) problems, liver dysfunction, skin rashes, and other symptoms can develop as acute (temporary) GVHD within 100 days of a transplant or as chronic GVHD months — or even years ...

The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...

The team explored the potential of regenerative mesenchymal stem cells in reducing ocular inflammation in GVHD-infected mice. Their study, published in The Ocular Surface, explores the potential of ...